Mako_Robot_TKA_NEW-0-600x566-1.jpg

MemorialCare Joint Replacement Center At Long Beach Memorial Now Offering Newest Technology In Total Knee Replacement

Posted On May 24, 2017 By OrthoSpineNews In Recon, Robotics, Top Stories /  

LONG BEACH, Calif., May 24, 2017 /PRNewswire-USNewswire/ — The MemorialCare Joint Replacement Center at Long Beach Memorial is the first hospital in Long Beach and North Orange County to offer Stryker’s robotic-arm assisted total knee application for use with its Mako System – and now has successfully performed its first total knee replacement case in that region using this new technology. This latest advancement in joint replacement surgery transforms the way total knee replacements are performed.

Total knee replacements in the United States are expected to increase 673 percent by 2030,1 yet studies have shown that approximately 30 percent of patients are dissatisfied after conventional surgery.2 Mako Total Knee combines Stryker’s advanced robotic technology with its clinically proven GetAroundKnee (Triathlon Total Knee System), which enabled surgeons to have a more predictable surgical experience with increased accuracy during laboratory testing.3

“Mako is changing the way joint replacement surgeries are performed by providing each patient with a personalized surgical experience based on their specific diagnosis and anatomy,” said Andrew Wassef, M.D., medical director, MemorialCare Joint Replacement Center, Long Beach Memorial. “Using a virtual 3D model, the Mako System allows surgeons to create each patient’s surgical plan pre-operatively before entering the operating room. During surgery, the surgeon can validate that plan and make any necessary adjustments while guiding the robotic-arm to execute that plan. It’s exciting to be able to offer this transformative technology across the joint replacement service line to perform total knee, total hip and partial knee replacements.”

The Mako Total Knee application is a knee replacement treatment option designed to relieve the pain caused by joint degeneration due to osteoarthritis. Through CT-based 3D modeling of bone anatomy, surgeons can use the Mako System to create a personalized surgical plan and identify the implant size, orientation and alignment based on each patient’s unique anatomy. The Mako System also enables surgeons to virtually modify the surgical plan intra-operatively and assists the surgeon in executing bone resections.

“We are proud to be the first hospital to offer this highly advanced robotic technology in our area,” said Tamra Kaplan, PharmD, chief operating officer, Long Beach Memorial. “This addition to our orthopaedic service line further demonstrates our commitment to provide the community with outstanding healthcare.”

About the MemorialCare Joint Replacement Center at Long Beach Memorial:

Long Beach Memorial is lauded for superior clinical quality outcomes and has been listed on U.S. News & World Report’s America’s Best Hospitals since the annual rankings began. In this year’s results, Long Beach Memorial received “high performance” rankings in nine clinical specialty areas, including Hip Replacement, Knee Replacement and Orthopedics. It also is among a small percentage of U.S. hospitals consistently recognized for outstanding dedication to patient safety by maintaining a top “A” grade in eight of nine Leapfrog Group Hospital Safety Score evaluations for its ability to prevent errors, injuries, accidents and infections.

JRC specializes in a rapid rehabilitation program – where patients walk the same day of surgery – resulting in a shorter hospital stay – average hospital stay is zero to two days. The JRC features a dedicated unit for joint replacement patients with 15 private rooms, a joint care coordinator to help patients navigate through the program, patient education before and after surgery and “rehab coaches” to provide support as patients take their first steps toward an active lifestyle.

1. Kurtz AAOS. Total knee and hip replacement projections 2030. www.prnewswire.com/news-releases/total-knee and-hip-replacement-surgery projections-show-meteoric-rise-by-2030-55519727.html. Accessed July 4, 2016. 2. Christiaan Keurentjes J, Fiocco M, So-Osman C, et al. Patients with severe radiographic osteoarthritis have better prognosis in physical functioning after hip and knee replacement: a cohort-study. PLOS One. 2013; 8(4): 1-8. 3. Hampp EL, Scholl LY, Prieto M, Chang T, Abbasi AZ, Bhowmik-Stoker M, Otto JK, Jacofsky DJ, Mont MA. “Accuracy Assessment of Robotic and Manual TKA in a Cadaveric Model.” Robotic-arm assisted total knee arthroplasty demonstrated greater accuracy to plan compared to manual technique. ORS 2017 Annual Meeting. San Diego. Poster No.2412.

SOURCE Long Beach Memorial

Read More
medtec_rosa.png

Zimmer Biomet licenses Intellectual Property from Bonutti Research Inc.

Posted On May 19, 2017 By OrthoSpineNews In Robotics, Top Stories /  

EFFINGHAM, ILLINOIS (PRWEB) MAY 18, 2017

Effingham, Illinois – May 18, 2017 – Bonutti Research Inc. and Zimmer Biomet have entered into a license agreement for Zimmer Biomet’s use of two patent families created by Dr. Peter Bonutti. U.S. Patent No. 9,301,845 adds to the strength of the innovative knee systems, Persona® The Personalized Knee System and the NexGen® Complete Knee Solution. U.S. Patent Nos. 9,269,987 and 9,585,725 support the development of the Rosa® robotic total knee application currently underway at Zimmer Biomet.

About Bonutti Research (BRI)

Founded by Peter Bonutti, MD in 1989, BRI is a medical device incubator with over 550 patents and patent applications involving diagnostics, surgical robotics, minimal invasive surgery, soft tissue fixation, and hip and knee arthroplasty. BRI has entered into over 740 licenses in numerous medical and surgical fields. Bonutti Research is a device incubator with in-house design, engineering, regulatory, manufacturing, and intellectual property teams.  Learn more about innovations from BRI at bonuttiresearch.com

Contact:
Lucas Wenthe
LWenthe(at)bonuttitechnologies(dot)com
(217) 342-3412 x5111

Read More
Titan-Medical-SPORT.png

Titan Medical Completes Initial Formative Human Factors Studies for SPORT Robotic Surgical System

Posted On May 17, 2017 By OrthoSpineNews In Robotics, Top Stories /  

TORONTO, ON–(Marketwired – May 17, 2017) – Titan Medical Inc. (TSX: TMD) (OTCQB: TITXF), a medical device company focused on the design and development of a robotic surgical system for application in minimally invasive surgery (MIS), announces completion of initial formative human factors studies for its SPORT single port robotic surgical system. Formative human factors studies involve the evaluation of prototypes by expert users that focus on simulated task exercises that are critical to product safety.

David McNally, President and CEO of Titan Medical, said, “The completion of initial formative human factors studies is a key development milestone, and we are pleased to have achieved it on schedule. We are grateful to the independent surgeons and nurses who participated in these studies. Initial formative human factors studies are a foundational step in the development of a safe and effective complex medical device, such as a robotic system. In addition to evaluating the ergonomics of the workstation and patient cart during simulated procedures, clinicians provided insights regarding the setup and maneuverability of the central unit, the positioning of the insertable camera and the loading of instruments. The results of the studies provide valuable perspectives on user interaction and user experience for the development of the SPORT system. This end-user feedback will be integrated with information gained from the ongoing testing and evaluation of certain subsystems, so that appropriate design enhancements can be prioritized and implemented.”

Mr. McNally continued, “Based on our progress and the commitment of our employees and subcontractors, we remain on track to deliver the next of our stated milestones during the second quarter of the year. While our product development team focuses on system design improvements, other members of management are actively engaged in evaluating prospective strategic facilities for preclinical studies in the U.S. and Europe.”

About Titan Medical Inc.

Titan Medical Inc. is focused on the design and development through to the planned commercialization of a robotic surgical system for application in MIS. Titan’s SPORT Surgical System, currently under development, includes a surgeon-controlled robotic platform that features multi-articulating instruments for performing MIS procedures through a single port. The surgical system also includes a workstation that provides a surgeon with an advanced ergonomic interface to the robotic platform for controlling the instruments and provides a 3D high-definition endoscopic view inside a patient’s body. The SPORT system is designed to enable surgeons to perform a broad set of general abdominal, gynecologic, urologic and colorectal procedures. For more information, visit the Company’s website at www.titanmedicalinc.com.

Forward-Looking Statements

This news release contains “forward-looking statements” which reflect the current expectations of management of the Company’s future growth, results of operations, performance and business prospects and opportunities. Wherever possible, words such as “may”, “would”, “could”, “will”, “anticipate”, “believe”, “plan”, “expect”, “intend”, “estimate”, “potential for” and similar expressions have been used to identify these forward-looking statements. These statements reflect management’s current beliefs with respect to future events and are based on information currently available to management. Forward-looking statements involve significant risks, uncertainties and assumptions. Many factors could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements that may be expressed or implied by such forward-looking statements, including, without limitation, those listed in the “Risk Factors” section of the Company’s Annual Information Form dated March 31, 2017 (which may be viewed at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward looking statements prove incorrect, actual results, performance or achievements may vary materially from those expressed or implied by the forward-looking statements contained in this news release. These factors should be considered carefully, and prospective investors should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in the news release are based upon what management currently believes to be reasonable assumptions, the Company cannot assure prospective investors that actual results, performance or achievements will be consistent with these forward-looking statements.

 

CONTACT INFORMATION

Read More
Hadassah-Surgeons-Perform-Worlds-First-Ever-Dual-Robotic-Surgery-in-Jerusalem-768x432.jpg

Surgeons Perform World’s First-Ever Dual Robotic Surgery at Jerusalem’s Hadassah Hospital

Posted On May 2, 2017 By OrthoSpineNews In Robotics, Top Stories /  

NEW YORK, April 28, 2017 /PRNewswire-USNewswire/ — The world’s first-of-its-kind dual robotic surgery was performed on April 23 at Hadassah Hospital Ein Kerem in Jerusalem, announced  National President Ellen Hershkin of Hadassah, the Women’s Zionist Organization of America, Inc. (HWZOA).

The revolutionary dual robotic surgery assisted in the repair of a severe spinal fracture suffered by Aharon Schwartz, 42, a factory worker in Jerusalem who was injured when a steel object pinned him to the ground, fracturing his leg in two places and breaking six of his spinal vertebrae.  The 3-hour surgery took place in the state-of-the-art $30M underground hybrid operating theater at Hadassah’s Sarah Wetsman Davidson Hospital Tower.

Dr. Meir Liebergall, Chairman of the Hadassah Medical Organization’s (HMO) Orthopedic Department and head of HMO’s Musculo-Skeletal Medicine Division, explained the pioneering surgery.  “Two robots, Siemens’ Artis Zeego and the Mazor Robotics’ Renaissance® Guidance System, were involved in the surgery.  Artis Zeego, overseen by Dr. Amal Khouri, Director of HMO’s Orthopedic Hospitalization Center, provided real-time 3-dimensional imaging during the surgical procedure, which eliminated the need for pre-surgery CT scans and post-surgery X-rays. Renaissance® Guidance System, a screw placement system which allows spinal implant placement with maximum safety and accuracy, was controlled by HMO Sr. Orthopedic Surgeon Dr. Josh Schroeder. Renaissance communicated with Artis Zeego during the minimally-invasive surgery while Dr. Schroeder led the Hadassah orthopedic team in the insertion of eleven pedicle screws into the patient’s spine with clinical exactitude.”

Dr. Liebergall predicted that patient Schwartz will completely recover from the surgery and will be walking again very shortly.

Hershkin states, “Once again, HMO achieves another world-first – a dual robot-assisted spinal surgery, solidifying its reputation for world class medical innovation and treatment.  Our congratulations go to Dr. Liebergall and his brilliant surgical team for continuing Hadassah’s mission of bringing ground-breaking medical care to the people of Israel.”

The Mazor Robotics Renaissance® Guidance System transforms spine surgery from freehand procedures to highly-accurate, state-of-the-art procedures that may reduce fluoroscopy—even for minimally-invasive surgery (MIS), scoliosis, and other complex spinal deformity cases.

The Siemens Artis Zeego® Robotic Technology enables smoother, swifter and trouble-free patient positioning and execution procedures.

Hadassah, the Women’s Zionist Organization of America, Inc. (HWZOA) is the largest Jewish women’s organization in the United States. With 330,000 members, associates and supporters Hadassah brings Jewish women together to effect change and advocate on critical issues such as medical care and research and women’s empowerment. Through the Hadassah Medical Organization’s two hospitals, the world-renowned trauma center and the leading research facility in Jerusalem, Hadassah supports the delivery of exemplary patient care to over a million people every year. HMO serves without regard to race, religion or nationality and earned a Nobel Peace Prize Nomination in 2005 for building “bridges to peace” through equality in medical treatment. For more information, visit www.hadassah.org.

SOURCE Hadassah, The Women’s Zionist Organization of America, Inc. (HWZOA)

Related Links

http://www.hadassah.org

Read More
Robotic_scope_and_instruments.jpg

Medrobotics® Corporation Flex® Robotic System Receives Best New Product Award at 2017 Edison Awards

Posted On May 1, 2017 By OrthoSpineNews In Robotics, Top Stories /  

May 01, 2017

RAYNHAM, Mass.–(BUSINESS WIRE)–Medrobotics Corp., a medical products company, announced today that its Flex®Robotic System received a Best New Product Award at the 2017 Edison Awards™. The Company’s rich history of innovation was recognized with a Bronze Award in the Surgical Tools category.

The Edison Awards™ is an annual competition honoring excellence in new product and service development, marketing, human-centered design, and innovation. The competition is open to progressive organizations across the globe. Award winners represent “game changing” products and services, as well as excellence and leadership in innovation. This year, more than 3,000 companies submitted applications. The winners were chosen as the “best of the best” by a panel comprised of individuals selected from the world’s top senior business executives, academics, and innovation professionals.

“Medrobotics is pleased the Flex® Robotic System has received this new recognition for its unique capabilities,” said Samuel Straface, Ph.D., President and CEO of Medrobotics. “Our products overcome the limits of traditional line-of-sight surgical technologies. Surgeons are now able to access difficult to reach anatomy through a single, small entry point and treat patients who might otherwise have required an open surgical procedure.”

Medrobotics’ Flex® Robotic System was designed to provide an affordable, easy-to-use robot-assisted surgical platform for hospitals and surgeons seeking to provide minimally-invasive treatment options to the broadest number of patients. Minimally invasive surgery has demonstrated advantages for patients and providers, such as shorter hospital stays and faster recovery times.

About Medrobotics

Medrobotics Corporation (www.Medrobotics.com) is a privately funded medical device company headquartered in Raynham, Massachusetts. It manufactures and markets the Flex® Robotic System, the world’s first robotic surgical platform with a steerable and shapeable robotic scope. The Flex® Robotic System offers surgeons the unique ability to navigate complex anatomy through a single, small entry point and operate in hard-to-reach anatomical locations that might otherwise be inaccessible with straight, rigid surgical tools. The Company’s vision is to provide more patients with access to minimally invasive surgery. Medrobotics received FDA clearance for the Flex® Robotic System in July 2015, and the CE mark in March 2014.

Contacts

Medrobotics Corp.
Kevin Knight, 214-732-9392

 

Read More
da-Vinci-X-System.jpg

Intuitive Surgical Receives CE Mark for Latest da Vinci® Robotic-Assisted Surgical System

Posted On April 28, 2017 By OrthoSpineNews In Regulatory, Robotics /  

AUBONNE, Switzerland, April 26, 2017 (GLOBE NEWSWIRE) — Intuitive Surgical, a global technology leader in robotic-assisted, minimally invasive surgery, announced today that its new da Vinci X Surgical System received CE Mark approval in Europe. The da Vinci X System will provide surgeons and hospitals with access to some of the most advanced robotic-assisted surgery technology at a lower cost.

The launch of the da Vinci X System underscores Intuitive’s commitment to meeting customers’ needs with a strong value-oriented portfolio of cost-appropriate technologies and an array of financing options.

“Over the past 21 years, Intuitive Surgical pioneered robotic-assisted surgery and we continue to lead the way in developing and bringing to market innovative technologies, outcomes-focused products and value-oriented solutions,” said Dr. Gary Guthart, CEO of Intuitive Surgical. “Our surgeon, hospital and healthcare customers around the world told us that robotic-assisted surgery matters for their programs and their patients while underscoring the importance of providing choice from a clinical, technological and cost standpoint. The da Vinci X product offering provides a lower-cost solution to meet the needs of customers who want a choice in price points, while offering access to many of our recent innovations.”

The da Vinci X System offers surgeons and hospitals access to Intuitive’s portfolio of advanced, innovative robotic-assisted surgical technologies – and its full ecosystem of programs, support, services, and solutions –at a lower price.  The System uses the same vision cart and surgeon consoles that are found on our flagship product, the da Vinci Xi® System, enabling our customers the option of adding advanced capabilities, and providing a pathway for upgrading should they choose to do so as their practice and needs grow.

The da Vinci X System enables optimized, focused-quadrant surgery including for procedures like prostatectomy, partial nephrectomy, hernia repair, benign hysterectomy and sacrocolpopexy, among others. The System features flexible port placement and state-of-the-art 3D digital optics, while incorporating the same advanced instruments and accessories as Intuitive’s flagship system. The new system drives operational efficiencies through set-up technology that uses voice and laser guidance, drape design that simplifies surgery prep, and a lightweight, fully integrated endoscope.

“The da Vinci X System is a value-oriented, highly capable offering that meets – and responds to – our customers’ economic and clinical needs,” said Damien Desmedt, General Manager of Intuitive Surgical in the United Kingdom, Ireland, and Nordic countries. “In the countries we serve around the globe, we know that customers have different needs and wants, and we strive to provide an array of choices to meet their needs today and in the future. The da Vinci X System helps us to continue to do this.”

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale, Calif., is a global technology leader in robotic-assisted, minimally invasive surgery. Intuitive Surgical develops, manufactures and markets the da Vinci Surgical System.

About the da Vinci Surgical System

There are several models of the da Vinci Surgical System. The da Vinci Surgical Systems are designed to help surgeons perform minimally invasive surgery. da Vinci Systems are not programmed to perform surgery on their own. Instead, the procedure is performed entirely by a surgeon who controls the system. da Vinci Systems offer surgeons high-definition 3D vision, a magnified view, and robotic and computer assistance. They use specialized instrumentation, including a miniaturized surgical camera and wristed instruments (i.e., scissors, scalpels and forceps) that are designed to help with precise dissection and reconstruction deep inside the body.

Intended Use

The Intuitive Surgical Endoscopic Instrument Control System (da Vinci X Surgical System Model IS4200) is intended to assist in the accurate control of Intuitive Surgical Endoscopic Instruments during urologic surgical procedures, general laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general thoracoscopic surgical procedures, thoracoscopically-assisted cardiotomy procedures, and trans-oral otolaryngology surgical procedures restricted to benign tumors and malignant tumors classified as T1 and T2, and for benign base of tongue resection procedures. The System can also be employed with adjunctive mediastinotomy to perform coronary anastomosis during cardiac revascularization.  The System is indicated for adult and pediatric use (except for trans-oral otolaryngology surgical procedures).  It is intended to be used by trained physicians in an operating room environment.

The da Vinci X Surgical System is a class 2b CE 0543 marked medical device under the European Medical Devices Directive (93/42/EEC) manufactured by Intuitive Surgical, Inc.  Refer to the Instructions For Use before use.

Forward Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding regulatory clearances to market the da Vinci X System in the US. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including those under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2016, as updated from time to time by our quarterly reports on Form 10-Q and our other filings with the Securities and Exchange Commission. Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “could,” “should,” “would,” “targeted” and similar words and expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.

© 2017 Intuitive Surgical, Inc. All rights reserved. Product names are trademarks or registered trademarks of their respective holders.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0c20bf18-fcc5-4d29-8bab-4ada1ab29eae

PN1035581rA EU 4/2017

Contact
JPA Health Communications
kperry@jpa.com
+44203 884 0650
Read More
348c424dd016faa93c9b2857e6a8.jpg

Sky Ridge Medical Center Acquires First Mazor X™ System in Ten-State Region

Posted On April 26, 2017 By OrthoSpineNews In Robotics, Spine, Top Stories /  

LONE TREE, Colo., April 25, 2017 /PRNewswire/ — Sky Ridge Medical Center acquired the first Mazor X™ system in Colorado and a ten-state region for spine surgery. The Sky Ridge Spine and Total Joint Center, a recipient of the Joint Commission Gold Seal of Approval, strives to improve patient outcomes with advanced technology and surgical techniques.

As part of its commitment to providing exceptional clinical care, Sky Ridge surgeons are now performing spine surgeries with the Mazor X™ system, which increases the efficiency and safety of spine surgery.

“The Mazor X™ system is setting a new standard of care. It is introducing technologies that link the knowledge and proficiency of our surgeons with digital data and analysis, enabling us to transform spine surgery, increasing its predictability for patients, surgeons and hospital teams,” said Susan Hicks, CEO, Sky Ridge Medical Center.

The Mazor X™ system creates a 3D model of the spinal cord that can be viewed from multiple angles. This 3D model helps surgeons identify potential challenges, better assess the patient’s anatomy to determine the best implants and develop a personalized care plan for each patient.

The system also includes tools that maximize stability during surgery. This, combined with imaging that increases the surgeon’s planning and visibility, results in increased precision with improved patient outcomes, including:

  • Fewer complications
  • Greater accuracy
  • Shorter surgeries
  • Faster recovery times

The Sky Ridge Spine & Total Joint Center offers:

  • Comprehensive team of specialists who provide personalized care before, during and after surgery.
  • Experienced physicians who perform more spine surgeries than any other hospital in Colorado.
  • Fellowship-trained neurosurgeons and orthopedic surgeons.
  • Best recovery environment in Colorado.
  • Most advanced technology, including minimally invasive surgery.
  • State-of-the-art, dedicated facility with private entrance.
  • Pre- and post-operative education.
  • Dedicated recovery floor with specialty-trained staff.

Media Contact:

Linda Watson
Director of Marketing & PR
720-979-7422
Linda.Watson@healthonecares.com

About Sky Ridge Medical Center

Sky Ridge Medical Center is a member of the HealthONE network. We work together to provide a higher level of care.

Visit www.skyridgemedcenter.com to learn more.

About Mazor Robotics

Mazor Robotics believes in healing through innovation by developing and introducing revolutionary technologies and products aimed at redefining the gold standard of quality care.

For more information, please visit www.mazorrobotics.com.

This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com

SOURCE Sky Ridge Medical Center

Related Links

http://www.skyridgemedcenter.com

Read More
davinci-robotic-surgery-large1-1.jpg

Intuitive Surgical Leads China Surgical Robotics Systems Market

Posted On April 21, 2017 By OrthoSpineNews In Robotics /  

VANCOUVER, British Columbia, April 21, 2017 /PRNewswire/ — According to a new series of reports on the China surgical navigation and robotics systems market by iData Research (www.idataresearch.com), the market in China is currently dominated by Intuitive Surgical, but has seen the entrance of companies such as Medtech and Accuray, predominantly in neurosurgery and radiosurgery applications. The market as a whole is expected to increase considerably as system sales increase and revenue from procedures, maintenance and services increases as a result of the growing installed base.

“The MIS robotic device market in China is the most mature and sees Intuitive Surgical as the market leader, but several companies are developing systems which will compete with Intuitive’s system,” explains Jeffrey Wong, Strategic Analyst Manager at iData Research. “As the installed base grows, the number of procedures will increase yearly, yielding a higher percentage of revenue from procedures.”

The Chinese robotic assisted surgery system market is expected to grow at a compound annual growth rate (CAGR) of over 14% through 2023 as a result of increasing adoption of robotic technologies in the neurosurgery, minimally invasive surgery (MIS), radiosurgery and spinal markets. Currently, the MIS, neurosurgery, and radiosurgery application segments are firmly established in China. Very small installed bases exist for systems with spinal applications and these are also expected to exhibit growth.

Overall, the surgical robotics market in China is still in its infancy. In addition to imported systems, several domestic companies are developing systems in a variety of procedural segments. Hong Kong has been a leading region for early system placements, with the first system, a da Vinci®, installed in Hong Kong’s Prince of Wales Hospital in 2005. As many robotics companies begin to expand partnerships with established medical device companies, sales of robotic surgery systems are expected to increase significantly. Gynecological procedures are the largest specialty of the da Vinci® system in China, followed by general surgery.

Additional competitors in the China robotic assisted surgery market include Accuray with their CyberKnife® system and Medtech who currently sells ROSA®, the only robotic surgery system approved for neurosurgical procedures by the China Food and Drug Administration (CFDA). Neurosurgical procedure applications include stereoelectroencephalography (SEEG) treatment for epilepsy, as well as hydrocephalus shunt, electrode placement, endoscopy and deep brain stimulation. It is expected that other companies will enter the Chinese market in the near future.

For Further Information

More on the surgical robotics market in China can be found in a series of reports published by iData Research entitled the China Market Report Suite for Surgical Navigation and Robotics Systems. The segmentation for surgical navigation includes systems with neurosurgery applications, spinal surgery applications, ear, nose and throat (ENT) applications, and orthopedic hip and knee applications. The segmentation for surgical robotics systems includes robotically assisted neurosurgery systems, minimally invasive surgery (MIS), robotically assisted radiosurgery systems and an appendix with qualitative data regarding robotically assisted spinal surgery systems.

The iData report series on robotic surgery systems covers the U.S., China, Australia, Japan, India and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about robotic surgery systems market data, register online or email us at info@idataresearch.net for a China Market Report Suite for Surgical Navigation and Robotics Systems brochure and synopsis.

About iData Research

iData Research (www.idataresearch.com) is an international market research and consulting firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Robotics and Surgical Navigation, Laparoscopy, Urology, Gynecology, Endoscopy, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Ophthalmics, Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Vascular Access, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics and more.

We have built a reputation and earned our clients’ trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success.

Contact Info
Marvin Cidamon
Marketing Coordinator
iData Research Inc.
604-266-6933 Ext. 205
marvinc@idataresearch.net

 

SOURCE iData Research

Related Links

https://www.idataresearch.com

Read More
da_vinci_surgical_not_properly_tested.jpg

Shares of this surgical robot maker just jumped to an all-time high on better-than-expected earnings

Posted On April 19, 2017 By OrthoSpineNews In Financial, Robotics /  

By:  |

Shares of Intuitive Surgical hit an all-time high Wednesday morning after the maker of the da Vinci surgery robot reported first-quarter earnings and sales that beat Street estimates.

The California-based company said it had earnings per share of $5.09 on sales of $674 million for the quarter, topping Thomson Reuters estimates for $4.93 on revenue of $669.7 million.

Important to Wall Street, Intuitive Surgical said Tuesday that it shipped 133 of its da Vinci surgical systems in the first quarter of 2017, compared with 110 robots delivered in the same period one year ago.

The stock traded up more than 7 percent, peaking at $811.89 per share Wednesday, and was on track for its best day since July 2015 when shares gained near 9 percent. Intuitive Surgical’s shares reached a low of $6 back in 2001.

 

READ THE REST HERE

 

Read More
slide-1.jpg

CMIS becomes 1st ASC in IL to add Robotics for Uni & Total Joint Reconstructive Surgery Procedures

Posted On April 18, 2017 By OrthoSpineNews In Recon, Robotics /  

Just over a year ago Surgical Care Affiliates, Inc. (“SCA”) partnered with the physician members of The Center for Minimally Invasive Surgery (“CMIS”) in Mokena, IL. The Partnership operates an ambulatory surgical facility that represents an important access point for high quality, low cost surgical services in Mokena and the surrounding region.

In April 2017 CMIS made yet another investment for our surgeon partners to provide superior clinical care at affordable costs as compared to typical hospital fees. CMIS is a unique ASC as it features the following to its surgeon partners and their patients:

  • 13 years of Total Joint & Complex Spine experience
  • AAAHC Accredited
  • Contracted with major commercial payors for high-acuity spine and total joint replacement
  • Unique Recovery Care Center allows for patients to stay overnight with nursing care for up to 48 hours or with Medical Director Review an additional 24hr may be implemented (typical length of stay is 1 night). Patients are treated to spacious private rooms and catered meals.
  • Advanced technology for spine including high power microscopes, Cell Saver capability, Neuromonitoring and O-arm Surgical Imaging System
  • Recent investment in updated Orthopedic equipment including Arthrex Synergy arthroscopy systems, Stryker Power (new overhead lights & towers not shown in image)
  • Anesthesiology group has served at center for over 10 years

 

READ THE REST HERE

 

Read More